Results 201 to 210 of about 36,199 (325)

Pharmacoepidemiology profile of Helicobacter pylori regimens in northern Italy

, 2001
Marisa De Rosa, Franco Bazzoli, Elisa Rossi, Rocco Maurizio Zagari, E. Roda   +4 more
openalex   +1 more source

Pharmacoepidemiology and “in silico” drug evaluation: is there common ground? [PDF]

, 2008
Til Stürmer‎, Kenneth J. Rothman, Jerry Avorn   +2 more
openalex   +1 more source

Use of semaglutide and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3094-3103, June 2025.
Abstract Aims To investigate the putative association between semaglutide and non‐arteritic anterior ischaemic optic neuropathy (NAION). Materials and Methods Data from national health registries in Denmark (2018–2024) and Norway (2018–2022) were used to compare NAION risk in individuals with type 2 diabetes initiating semaglutide versus sodium‐glucose
Emma Simonsen, Lars Christian Lund, Martin Thomsen Ernst, Vidar Hjellvik, Laszlo Hegedüs, Steffen Hamann, Øystein Kalsnes Jørstad, Hanne Løvdal Gulseth, Øystein Karlstad, Anton Pottegård   +9 more
wiley   +1 more source

Current awareness: Pharmacoepidemiology and drug safety [PDF]

, 2008

openalex   +1 more source

Real‐world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3185-3194, June 2025.
Abstract Aims To understand real‐world tirzepatide use among individuals without type 2 diabetes (T2D) diagnoses in a US electronic health record (EHR) database. Materials and Methods This retrospective, descriptive, cohort study used Veradigm's® Network EHR database linked with administrative claims.
Theresa Hunter Gibble, Chanadda Chinthammit, Jennifer M. Ward, Katherine Cappell, Robert Sedgley, Machaon Bonafede, Birong Liao, Emily R. Hankosky   +7 more
wiley   +1 more source

Characterization of treatment intensified (add‐on to metformin) adults with type 2 diabetes in Thailand: A cross‐sectional real‐world study (CONVERGE)

Journal of Diabetes Investigation, Volume 16, Issue 6, Page 1010-1019, June 2025.
The CONVERGE study retrospectively analyzed data from medical records of 1,000 adults with type 2 diabetes in Thailand from 2013 to 2017. The study provided insights into demographics, clinical characteristics, and treatment patterns. Findings indicated suboptimal utilization of cardioprotective glucose‐lowering agents such as GLP‐1RAs and SGLT‐2is ...
Chutintorn Sriphrapradang, Ammarin Thakkinstian, Ratiporn Chinthammit, Gurudutt Nayak   +3 more
wiley   +1 more source

Pharmacoepidemiology of Cellular/Tissue Derived Products for the Treatment of Venous Leg Ulcers in Outpatient Care Settings [PDF]

, 2014
Adrienne M. Gilligan, Curtis Waycaster
openalex   +1 more source

2 ． Overview of the DeSC Database and Utilization for Clinical Epidemiology and Pharmacoepidemiology Research

Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 2022
A. Okada, H. Yasunaga
semanticscholar   +1 more source

Impact of Discontinuation of Fall‐Risk‐Increasing Drugs on Falls in Multimorbid Older Patients With Polypharmacy

Journal of the American Geriatrics Society, Volume 73, Issue 6, Page 1827-1835, June 2025.
ABSTRACT Background Falls are a major concern in the older population. An important cause of falls is fall‐risk‐increasing drugs (FRID). However, it is not known if the discontinuation of FRID leads to a reduction of falls. Therefore, the aim of this study was to assess the association between discontinuation of FRID and the occurrence of falls and ...
Namiko A. Goto, Dayna A. M. van Heel, Lauren Dautzenberg, François‐Xavier Sibille, Emma Jennings, Douglas C. Bauer, Carole E. Aubert, Anne Spinewine, Nicolas Rodondi, Huiberdina L. Koek, Mariëlle H. Emmelot‐Vonk, Wilma Knol   +11 more
wiley   +1 more source

Editorial: Emerging trends in real-world pharmacoepidemiology: 2023. [PDF]

Front Pharmacol
Salahudeen MS, Da Silva Dal Pizzol T, Kao LT, Peterson GM.   +3 more
europepmc   +1 more source